Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) - Mease, PJ; Fleischmann, R; Deodhar, AA (Annals of the rheumatic diseases, 2014)
et al.